Identifying chronic rhinosinusitis without nasal polyps by analyzing aspirated nasal air with an electronic nose based on differential mobility spectrometry. (1st June 2022)

• Record Type: Journal Article
• Authors: Virtanen, Jussi; Kontunen, Anton; Numminen, Jura; Oksala, Niku; Rautiainen, Markus; Roine, Antti; Kivekäs, Ilkka
• Is Part Of: Acta oto-laryngologica. Volume 142:Number 6(2022)
• Page Start: 524
• Page End: 531
• Publication Date: 2022-06-01
• Subjects: Chronic rhinosinusitis -- differential mobility spectrometry -- electronic nose -- nasal air; Otolaryngology -- Periodicals; Ear -- Diseases -- Periodicals; Throat -- Diseases -- Periodicals; Otolaryngology -- Electronic Resources; Otorhinolaryngologic Diseases; 617.8
• DOI: 10.1080/00016489.2022.2093397
• Languages: English
• ISSNs: 0001-6489

Abstract

Abstract: Background: The diagnosis of chronic rhinosinusitis (CRS) is a complicated procedure. An electronic nose (eNose) is a novel method that detects disease from gas-phase mixtures, such as human breath. Aims/Objectives: To determine whether an eNose based on differential mobility spectrometry (DMS) can detect chronic rhinosinusitis without nasal polyps (CRSsNP) by analyzing aspirated nasal air. Materials and methods: Adult patients with CRSsNP were examined. The control group consisted of patients with septal deviation. Nasal air was aspirated into a collection bag and analyzed with DMS. The DMS data were classified using regularized linear discriminant analysis (LDA) models with 10-fold cross-validation. Results: The accuracy of the DMS to distinguish CRSsNP from patients with septal deviation was 69%. Sensitivity and specificity were 67 and 70%, respectively. Bonferroni-corrected statistical differences were clearly noted. When a subgroup with more severe inflammatory disease was compared to controls, the classification accuracy increased to 82%. Conclusions: The results of this feasibility study demonstrate that CRSsNP can potentially be differentiated distinguished from patients with similar nasal symptoms by analyzing the aspirated nasal air using DMS. Further research is warranted to evaluate the ability of this novel method in the differential diagnostics of CRS.